Lars Erik Böttiger

911 total citations
12 papers, 701 citations indexed

About

Lars Erik Böttiger is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Hematology. According to data from OpenAlex, Lars Erik Böttiger has authored 12 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Hematology. Recurrent topics in Lars Erik Böttiger's work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Lars Erik Böttiger is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Erythrocyte Function and Pathophysiology (2 papers). Lars Erik Böttiger collaborates with scholars based in Sweden. Lars Erik Böttiger's co-authors include Lars A. Carlson, Blenda Böttiger, M Myrhed, Ragnhild Gullberg, Olle Vikrot and Ragnar Berlin and has published in prestigious journals such as Atherosclerosis, Journal of Internal Medicine and PubMed.

In The Last Decade

Lars Erik Böttiger

12 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Erik Böttiger Sweden	8	399	229	206	119	118	12	701
LarsA. Carlson Sweden	3	349 0.9×	269 1.2×	214 1.0×	115 1.0×	121 1.0×	3	761
Sven Chr. Enger Norway	13	329 0.8×	230 1.0×	256 1.2×	131 1.1×	156 1.3×	17	750
Maurice A. Mishkel Canada	14	355 0.9×	312 1.4×	222 1.1×	133 1.1×	200 1.7×	21	930
I. Trayner United Kingdom	16	258 0.6×	355 1.6×	131 0.6×	173 1.5×	87 0.7×	24	763
Gerd Assmann Germany	7	472 1.2×	447 2.0×	275 1.3×	145 1.2×	71 0.6×	8	888
R H Neary United Kingdom	13	358 0.9×	169 0.7×	177 0.9×	46 0.4×	79 0.7×	28	678
Yitzhak Beigel Israel	19	173 0.4×	304 1.3×	152 0.7×	110 0.9×	113 1.0×	50	790
Strong Jp United States	16	172 0.4×	320 1.4×	416 2.0×	113 0.9×	79 0.7×	35	925
L.D. Dikkeschei Netherlands	15	306 0.8×	262 1.1×	151 0.7×	99 0.8×	147 1.2×	41	873
Gerald Klose Germany	13	218 0.5×	222 1.0×	130 0.6×	94 0.8×	65 0.6×	43	547

Countries citing papers authored by Lars Erik Böttiger

Since Specialization

Citations

This map shows the geographic impact of Lars Erik Böttiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Erik Böttiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Erik Böttiger more than expected).

Fields of papers citing papers by Lars Erik Böttiger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Erik Böttiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Erik Böttiger. The network helps show where Lars Erik Böttiger may publish in the future.

Co-authorship network of co-authors of Lars Erik Böttiger

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Erik Böttiger. A scholar is included among the top collaborators of Lars Erik Böttiger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Erik Böttiger. Lars Erik Böttiger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Böttiger, Lars Erik. (2001). Drug safety - important to us all!. Journal of Internal Medicine. 250(4). 269–270. 1 indexed citations

Böttiger, Lars Erik. (1989). Journal of Internal Medicine—a Phoenix!. Journal of Internal Medicine. 225(1). 1–2. 7 indexed citations

Böttiger, Lars Erik. (1987). The Heparin Story. Acta Medica Scandinavica. 222(3). 195–200. 3 indexed citations

Carlson, Lars A. & Lars Erik Böttiger. (1985). Risk Factors for Ischaemic Heart Disease in Men and Women:Results of the 19‐Year Follow‐up of the Stockholm Prospective Study. Acta Medica Scandinavica. 218(2). 207–211. 146 indexed citations

Böttiger, Lars Erik. (1984). Waldenström's Macroglobulinemia—40th Anniversary. Acta Medica Scandinavica. 216(5). 433–434. 2 indexed citations

Carlson, Lars A. & Lars Erik Böttiger. (1981). Serum triglycerides, to be or not to be a risk factor for ischaemic heart disease?. Atherosclerosis. 39(3). 287–291. 62 indexed citations

Böttiger, Lars Erik & Blenda Böttiger. (1981). Incidence and Cause of Aplastic Anemia, Hemolytic Anemia, Agranulocytosis and Thrombocytopenia. Acta Medica Scandinavica. 210(1-6). 475–479. 39 indexed citations

Carlson, Lars A., et al.. (1979). Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol.. PubMed. 206(5). 351–60. 223 indexed citations

Carlson, Lars A., et al.. (1979). Risk Factors for Myocardial Infarction in the Stockholm Prospective Study. Acta Medica Scandinavica. 206(1-6). 351–360. 179 indexed citations

10.

Myrhed, M, et al.. (1977). Alcohol Consumption and Hematology. Acta Medica Scandinavica. 202(1-6). 11–15. 27 indexed citations

11.

Berlin, Ragnar, Lars Erik Böttiger, & Olle Vikrot. (1973). LYSOLECITHIN AS A FACTOR INFLUENCING ERYTHROCYTE SEDIMENTATION RATE. Acta Medica Scandinavica. 194(1-6). 371–375. 3 indexed citations

12.

Gullberg, Ragnhild, et al.. (1966). Precipitating Serum Antibodies to Intrinsic Factor in Pernicious Anemia. Acta Medica Scandinavica. 180(1). 87–94. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact